BRCA2 and Familial prostate cancer: Individuals who may have family history of prostate cancer and positive for BRCA2 mutation have higher rates of progression/grade reclassification while on active surveillance (AS), and lower metastasis free and overall survival after primary treatment [19,20,21,22,23].